DESTINY-PanTumor02 is a global, multicenter, multi-cohort, open-label phase 2 trial evaluating the efficacy and safety of ENHERTU (5.4 mg/kg) for the treatment of previously treated HER2 expressing ...

Fractyl Health announced a first-in-human trial for RJVA-001, targeting T2D and obesity, pending regulatory approval by 2026. Fractyl Health, Inc. has announced the submission of the first module of ...

Following its Type A meeting with the FDA, Replimune reported that a forward pathway “has not been determined” to obtain ...

Prior to completing an application, you will need to satisfy training requirements. The Human Subject Research Orientation on Canvas will ultimately save you time in ...

Lilly Pill Cuts Body Weight by 10.5% in Patients With Type 2 Diabetes By Patrick Wingrove (Reuters) -Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes ...

Share on Pinterest A new study finds an insulin taken once a week may help people control their blood sugar levels. Oscar Wong/Getty Images A new study finds that a once-a-week insulin shot may help ...

Researchers have investigated the link between fatty liver disease and key markers of type 2 diabetes in mice. The results suggest that reducing production of the neurotransmitter GABA in the liver ...